Two-year follow-up of bioresorbable vascular scaffolds in severe infra-popliteal arterial disease.

CONCLUSIONS: At 24 months, our study found that patients with predominantly advanced infra-popliteal PAD who were treated with Absorb bioresorbable vascular scaffold reported improved clinical status and a low and durable rate of clinically driven target vessel failure extending out to 24 months. PMID: 32921290 [PubMed - as supplied by publisher]
Source: Vascular - Category: Surgery Authors: Tags: Vascular Source Type: research
More News: Bleeding | Study | Surgery | Thrombosis